Is gadolinium harming animals in the ocean?

With almost half a billion doses of gadolinium administered to patients across the world, traces of the imaging element have been detected in the waterways of many countries. A recent study has raised concerns of the effect on marine animals. 

Certain creatures, such as Cnidaria (which include jellyfish), small plankton and species of algae are more sensitive to gadolinium, according to a story in Hakai Magazine.

The new research found the extent to which gadolinium affects these marine animals is still unknown, but the team noted it’s also possible for the chemicals to cycle back to humans through animals or plants that absorb the contrast agent.

“We don’t put only one pollutant into [the] marine [environment]. We put a lot of different compounds. [So] this is the big issue,” said coauthor of the study Ewa Olkowska.

Read the entire story below:

""

Matt joined Chicago’s TriMed team in 2018 covering all areas of health imaging after two years reporting on the hospital field. He holds a bachelor’s in English from UIC, and enjoys a good cup of coffee and an interesting documentary.

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.